ENAapplication/xmlftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR293/086/SRR29381186/SRR29381186.fastq.gzftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR293/075/SRR29381175/SRR29381175.fastq.gzftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR239/068/SRR23928368/SRR23928368.fastq.gzftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR239/070/SRR23928370/SRR23928370_2.fastq.gzftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR239/069/SRR23928369/SRR23928369_1.fastq.gzftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR239/069/SRR23928369/SRR23928369.fastq.gzftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR239/075/SRR23928375/SRR23928375_2.fastq.gzftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR293/081/SRR29381181/SRR29381181.fastq.gzftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR293/079/SRR29381179/SRR29381179.fastq.gzftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR293/073/SRR29381173/SRR29381173.fastq.gzftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR293/080/SRR29381180/SRR29381180.fastq.gzftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR293/084/SRR29381184/SRR29381184.fastq.gzftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR239/068/SRR23928368/SRR23928368_2.fastq.gzftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR293/087/SRR29381187/SRR29381187.fastq.gzftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR293/076/SRR29381176/SRR29381176.fastq.gzftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR239/074/SRR23928374/SRR23928374_2.fastq.gzftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR239/071/SRR23928371/SRR23928371_2.fastq.gzftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR239/073/SRR23928373/SRR23928373_1.fastq.gzftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR239/070/SRR23928370/SRR23928370_1.fastq.gzftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR239/075/SRR23928375/SRR23928375_1.fastq.gzftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR239/067/SRR23928367/SRR23928367_1.fastq.gzftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR239/071/SRR23928371/SRR23928371_1.fastq.gzftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR293/083/SRR29381183/SRR29381183.fastq.gzftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR293/072/SRR29381172/SRR29381172.fastq.gzftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR239/069/SRR23928369/SRR23928369_2.fastq.gzftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR293/088/SRR29381188/SRR29381188.fastq.gzftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR239/073/SRR23928373/SRR23928373_2.fastq.gzftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR239/072/SRR23928372/SRR23928372_2.fastq.gzftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR293/077/SRR29381177/SRR29381177.fastq.gzftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR239/074/SRR23928374/SRR23928374_1.fastq.gzftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR293/082/SRR29381182/SRR29381182.fastq.gzftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR239/068/SRR23928368/SRR23928368_1.fastq.gzftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR239/067/SRR23928367/SRR23928367.fastq.gzftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR239/072/SRR23928372/SRR23928372_1.fastq.gzftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR293/085/SRR29381185/SRR29381185.fastq.gzftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR239/067/SRR23928367/SRR23928367_2.fastq.gzftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR293/078/SRR29381178/SRR29381178.fastq.gzftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR293/074/SRR29381174/SRR29381174.fastq.gzftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR293/089/SRR29381189/SRR29381189.fastq.gzprimaryOK200GenomicsNeurology, Brigham and Women's Hospitalhttps://www.ebi.ac.uk/ena/browser/view/PRJNA947105Homo sapiensxref:PubMed:37425921A growing number of studies describe multiple functions of lncRNAs in chromatin that support their active roles in normal and disease-specific gene expression. We identified a specific enhancer-associated LINC01116 (named HOXDeRNA), which targeted activation transformed human astrocytes into glioma-like cells. Using a combination of RNA-Seq, ChIRP-Seq, and ChIP-Seq, we defined the transcriptomic and epigenetic changes underlying the transformation. We demonstrate that HOXDeRNA binds in trans to the promoters of 44 glioma-specific transcription factors distributed throughout the genome and derepresses them by removing the Polycomb 2 complex. This process is mediated by the RNA G-quadruplex structure of HOXDeRNA. Moreover, HOXDeRNA-induced astrocyte transformation is accompanied by the activation of glioma-specific super-enhancers enriched for binding sites of glioma master transcription factors SOX2 and OLIG2, and multiple oncogenes such as EGFR, PDGFR, BRAF, and miR-21. Our results help reconstruct the sequence of events underlying the process of astrocyte transformation and suggest a driving role of HOXDeRNA eRNA in gliomagenesis. Overall design: mRNA-Seq was performed on fetal human astrocytes, Immortalized dCas9 expressing astrocytes (NHA) transduced with sgRNA non-targeting control and custom-made Edit-R CRISPRa human HOXDeRNA lentiviral sgRNAsENAfalseGenome-wide activation of a glioma cancerous transcription program and super-enhancers by a single enhancer HOXDeRNA [RNA-seq]Genome-wide activation of a glioma cancerous transcription program and super-enhancers by a single enhancer HOXDeRNA [RNA-seq]2025-09-242023-04-05PRJNA947105GSE227802960637425921